These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 7936100)
41. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954 [TBL] [Abstract][Full Text] [Related]
42. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Hu XT; Brooderson RJ; White FJ Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592 [TBL] [Abstract][Full Text] [Related]
43. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity. Sammut S; Bray KE; West AR Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493 [TBL] [Abstract][Full Text] [Related]
44. D1 receptors modulate striatal dopamine release induced by the stimulation of both D1 and D2 receptors: in vivo voltammetric data revisited. Fechtali T; Issoual D; Abraini JH J Physiol Paris; 1994; 88(5):331-3. PubMed ID: 7787831 [TBL] [Abstract][Full Text] [Related]
46. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements. Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482 [TBL] [Abstract][Full Text] [Related]
47. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors. Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937 [TBL] [Abstract][Full Text] [Related]
48. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model. Rehders JH; Löscher W; Richter A Neuroscience; 2000; 97(2):267-77. PubMed ID: 10799758 [TBL] [Abstract][Full Text] [Related]
49. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL; Rose S; Jenner P; Marsden CD Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631 [TBL] [Abstract][Full Text] [Related]
50. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates. Byrnes EM; Bruno JP Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729 [TBL] [Abstract][Full Text] [Related]
51. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors. Pollack AE; Wooten GF Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196 [TBL] [Abstract][Full Text] [Related]
52. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum. Zhang X; Segawa T Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545 [TBL] [Abstract][Full Text] [Related]
53. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Arnt J; Hyttel J Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689 [TBL] [Abstract][Full Text] [Related]
54. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study. Gnanalingham KK; Robertson RG Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447 [TBL] [Abstract][Full Text] [Related]
55. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. See RE; Sorg BA; Chapman MA; Kalivas PW Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300 [TBL] [Abstract][Full Text] [Related]
56. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs. Cho S; Neff NH; Hadjiconstantinou M Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833 [TBL] [Abstract][Full Text] [Related]
57. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
58. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790 [TBL] [Abstract][Full Text] [Related]
59. Do D1/D2 interactions regulate prepulse inhibition in rats? Wan FJ; Taaid N; Swerdlow NR Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194 [TBL] [Abstract][Full Text] [Related]
60. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo. Riddall DR Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]